Abstract: The present invention relates to the uses of sesquiterpene lactone compounds and their derivatives in preparing drugs. It belongs to the field of drug technology, specifically relates to the uses of the compounds of Formula (I) in preparing the drugs, especially the uses in preparing the drugs to treat rheumatoid arthritis and treat cancers through inhibiting cancer stem cells.
Abstract: The present invention provides an application of a dimethylamino micheliolide for preparing a pharmaceutical product for treating pulmonary fibrosis.
Type:
Grant
Filed:
January 28, 2016
Date of Patent:
March 5, 2019
Assignees:
Tianjin International Joint Academy of Biotechnology & Medicine, ACCENDATECH
Abstract: The present invention provides an application of a dimethylamino micheliolide for preparing a pharmaceutical product for treating pulmonary fibrosis.
Type:
Application
Filed:
January 28, 2016
Publication date:
January 3, 2019
Applicants:
Tianjin International Joint Academy of Biotechnology & Medicine, ACCENDATECH